|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ADAP | Norry Elliot | Chief Medical Officer | Jan 16 | Sale | 0.79 | 2,287 | 1,807 | 3,363 | Jan 17 05:31 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 17 | Sale | 0.67 | 18,276 | 12,300 | 7,785 | Jan 17 05:31 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 11 | Sale | 0.84 | 4,009 | 3,354 | 6,104 | Jan 12 05:00 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 12 | Sale | 0.85 | 7,799 | 6,661 | 11,841 | Jan 12 05:00 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 17 | Sale | 1.86 | 2,159 | 4,011 | 3,491 | Jan 17 09:16 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 11 | Sale | 1.75 | 3,843 | 6,713 | 6,270 | Jan 12 09:01 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 12 | Sale | 1.71 | 7,449 | 12,708 | 12,191 | Jan 12 09:01 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 04 | Sale | 1.69 | 876 | 1,484 | 1,361 | Jan 04 09:01 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 18 | Sale | 3.19 | 2,121 | 6,770 | 3,529 | Jan 18 09:02 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 11 | Sale | 3.56 | 3,770 | 13,409 | 6,343 | Jan 13 09:01 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 12 | Sale | 3.54 | 854 | 3,027 | 1,383 | Jan 13 09:01 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 04 | Sale | 4.06 | 849 | 3,451 | 1,388 | Jan 05 09:05 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 19 | Sale | 5.67 | 2,111 | 11,968 | 3,539 | Jan 19 09:01 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 12 | Sale | 6.15 | 841 | 5,174 | 1,396 | Jan 12 09:00 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 04 | Sale | 5.33 | 845 | 4,502 | 1,392 | Jan 05 09:00 PM |
ADAP | Norry Elliot | Chief Medical Officer | Jan 14 | Sale | 5.13 | 911 | 4,678 | 1,326 | Jan 15 08:03 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite